Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vaccination against the extra domain‐B of fibronectin as a novel tumor therapy

15 Jul 2010

Abstract excerpt

Monoclonal antibody-based therapies have made an important contribution to current treatment strategies for cancer and autoimmune disease. However, the cost for these new drugs puts a significant strain on the health-care economy, resulting in limited availability for patients. Therapeutic vaccination, defined as induction of immunity against a disease-related self-molecule, is therefore an attractive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Adhesion Molecules Research
Share to Immunotherapy and Immune Responses
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20634349
DOI: 10.1096/fj.10-163022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vaccination against the extra domain‐B of fibronectin as a novel tumor therapyPMID 20634349Read ↗

A high‐affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo‐vasculature <i>in vivo</i>Semantic proximity Read ↗

Diagnostic and Therapeutic Applications of Recombinant Antibodies:Targeting the Extra-Domain B of Fibronectin, A Marker of Tumor AngiogenesisSemantic proximity Read ↗

Exploring the mechanism of fibronectin extra domain B in the tumor microenvironment and implications for targeted immunotherapy and diagnostics (Review)Semantic proximity Read ↗

Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domainSemantic proximity Read ↗

Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8.Semantic proximity Read ↗

Targeting Oncofetal Fibronectin and Neuropilin-1 in solid tumors with PL2 peptideSemantic proximity Read ↗

DNA Vaccine Against Tumor Endothelial Marker 8 Inhibits Tumor Angiogenesis and GrowthSemantic proximity Read ↗

C6: A Monoclonal Antibody Specific for a Fibronectin Epitope Situated at the Interface between the Oncofoetal Extra-Domain B and the Repeat III8.Semantic proximity Read ↗

Different tissue distribution properties for glycosylation variants of fusion proteins containing the p40 subunit of murine interleukin-12.Semantic proximity Read ↗

Engineering murine GITRL for antibody-mediated delivery to tumor-associated blood vesselsSemantic proximity Read ↗

DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis.Semantic proximity Read ↗

EDB-FN-Targeted Positron Emission Tomography Imaging of Breast Cancer in MiceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.